Expert Opinion on Investigational Drugs

Novel biologic mechanisms of levosimendan and its effect on the failing heart
pp. 1143-1150(8)
Authors: Parissis, John T; Andreadou, Ioanna; Bistola, Vassiliki; Paraskevaidis, Ioannis; Filippatos, Gerasimos; Kremastinos, Dimitrios T

Plant histaminase as an investigational drug in splanchnic artery occlusion and reperfusion
pp. 1151-1160(10)
Authors: Cuzzocrea, Salvatore; Masini, Emanuela

Induced hypothermia in acute ischemic stroke
pp. 1161-1174(14)
Authors: Lazzaro, Marc A; Prabhakaran, Shyam

Carbamylated erythropoietin to treat neuronal injury: new development strategies
pp. 1175-1186(12)
Author: Lapchak, Paul A

New drugs in development for the treatment of endometriosis
pp. 1187-1202(16)
Authors: Fedele, Luigi; Somigliana, Edgardo; Frontino, Giada; Benaglia, Laura; Vigano, Paola

Anti-TNF-α therapies in chronic obstructive pulmonary diseases
pp. 1203-1211(9)
Authors: Antoniu, Sabina A; Mihaltan, Florin; Ulmeanu, Ruxandra

Inflammatory lipids as a target for therapy in the rheumatic diseases
pp. 1213-1224(12)
Authors: McMahon, Maureen; Brahn, Ernest

Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme
pp. 1225-1235(11)
Authors: Reardon, David A; Nabors, L Burt; Stupp, Roger; Mikkelsen, Tom

ZD4054: a specific endothelin A receptor antagonist with promising activity in metastatic castration-resistant prostate cancer
pp. 1237-1245(9)
Authors: Warren, Ruth; Liu, Glenn

Promising antitumor activity with MGCD0103, a novel isotype-selective histone deacetylase inhibitor
pp. 1247-1254(8)
Authors: Tourneau, Christophe Le; Siu, Lillian L

Darusentan: a new perspective for treatment of resistant hypertension?
pp. 1255-1263(9)
Authors: Enseleit, Frank; F Lüscher, Thomas; Ruschitzka, Frank

Erratum
pp. 1265-1265(1)